Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VIIDiana Crivellari, Karen N. Price, Alan S. Coates et al.|Journal of Clinical Oncology|2000Cited by 295
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?Stefan Aebi, Aron Goldhirsch, Shari Gelber et al.|The Lancet|2000Cited by 286
Identifying Breast Cancer Patients at High Risk for Bone MetastasesMarco Colleoni, Anne O’Neill, Aron Goldhirsch et al.|Journal of Clinical Oncology|2000Cited by 125
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXStefan Aebi, Aron Goldhirsch, Zijie Sun et al.|Annals of Oncology|2011Cited by 55